PROGRESS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL PURPOSES

Recombinant human serum albumin (OsrHSA) has emerged as a substantial innovation in the field of biopharmaceuticals, providing promising advancements throughout a variety of medical and industrial purposes. With its structural similarity to Obviously derived human serum albumin, OsrHSA presents a safer, much more dependable substitute for therapeut